Abstract
Phosphorus depletion describes a state of substantial phosphorus deficiency within all body compartments. Most, but not all times, it is accompanied by hypophosphatemia, a serum phosphorus level of <2.5 mg/dl (<0.81 mmol/L). While hypophosphatemia is rare in the general population, among hospitalized patients, there are several high-risk subgroups, including alcoholics and the severely malnourished (e.g., those with anorexia nervosa and malignancy) [1, 2]. As phosphorus-containing ATP forms the basis of energy that is essential to most physiologic processes, significant deficiency in this element is a threat to health. Severe hypophosphatemia (≤1.0 mg/dl) has been linked to the syndrome of phosphorus depletion, characterized symptomatically by weakness, muscle and bone pain, and anorexia [3]. Animal data, human case reports, and observational human studies have demonstrated multisystem effects, including respiratory and cardiac muscle dysfunction, rhabdomyolysis, osteomalacia, and hemolysis [4]. Given the diverse and central role of phosphorus, intuition would suggest that the phosphorus-depletion syndrome enhances risk for mortality, especially in the critically ill patient. However, while observational data shows an association between severe hypophosphatemia and mortality, confounding by a variety of comorbid conditions in the critically ill makes causality difficulty to prove [2].
In addition, the exact clinical and laboratory threshold at which a patient becomes at risk for the syndrome is unknown. Hence, it is paramount to recognize the constellation of symptoms and signs and identify the risk factors for development of phosphate-depletion syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60(4):655–61.
Brunelli SM, Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol: JASN. 2007;18(7):1999–2003.
Lotz M, Zisman E, Bartter FC. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968;278(8):409–15.
Knochel J. Deranged phosphorus metabolism. In: Donald W, Seldin GHG, editors. The kidney: physiology and pathophysiology. 1st ed. New York: Raven; 1985. p. 1397–414.
Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118(10):1094–101.
Iheagwara OS, Ing TS, Kjellstrand CM, Lew SQ. Phosphorus, phosphorous, and phosphate. Hemodial Int Int Symp Home Hemodial. 2012;17(4):479–82.
Mostellar ME, Tuttle Jr EP. Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate in man. J Clin Invest. 1964;43:138–49. Pubmed Central PMCID: 289504.
Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med. 1985;79(5):571–6.
Knochel JP. Hypophosphatemia in the alcoholic. Arch Intern Med. 1980;140(5):613–5.
Imel EA, Econs MJ. Approach to the hypophosphatemic patient. J Clin Endocrinol Metab. 2012;97(3):696–706. Pubmed Central PMCID: 3319220.
Giovannini I, Chiarla C, Nuzzo G. Pathophysiologic and clinical correlates of hypophosphatemia and the relationship with sepsis and outcome in postoperative patients after hepatectomy. Shock. 2002;18(2):111–5.
Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010;103(7):449–59.
Schnitker MA, Mattman PE, Bliss TL. A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951;35(1):69–96.
Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med. 1992;92(5):455–7.
Bouquegneau A, Dubois BE, Krzesinski JM, Delanaye P. Anorexia nervosa and the kidney. Am J Kidney Dis: Off J National Kidney Foundat. 2012;60(2):299–307.
Salomon O, Holtzman EJ, Beckerman P, Avivi C, Trakhtenbrot L, Kneller A, et al. Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hypophosphatemia at the time of blast crisis of Phneg CML to acute myelomoncytic leukemia. Exper Hematol Oncol. 2012;1(1):24. Pubmed Central PMCID: 3514108.
Steiner M, Steiner B, Wilhelm S, Freund M, Schuff-Werner P. Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2000;25(9):1015–6.
Investigators RRTS, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–38.
Network VNARFT, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20. Pubmed Central PMCID: 2574780.
Knochel JP. The clinical status of hypophosphatemia: an update. N Engl J Med. 1985;313(7):447–9.
Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2003;88(8):3591–7.
Simonson D, DeFronzo RA. Hypophosphatemia and glucose intolerance. Adv Exp Med Biol. 1982;151:217–28.
O’Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med. 1977;297(17):901–3.
Darsee JR, Nutter DO. Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia. Ann Intern Med. 1978;89(6):867–70.
Davis SV, Olichwier KK, Chakko SC. Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci. 1988;295(3):183–7.
Agusti AG, Torres A, Estopa R, Agustividal A. Hypophosphatemia as a cause of failed weaning: the importance of metabolic factors. Crit Care Med. 1984;12(2):142–3.
Aubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985;313(7):420–4.
Gravelyn TR, Brophy N, Siegert C, Peters-Golden M. Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population. Am J Med. 1988;84(5):870–6.
Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplantat. 2011;26(11):3508–14.
Jacob HS, Amsden T. Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med. 1971;285(26):1446–50.
Craddock PR, Yawata Y, VanSanten L, Gilberstadt S, Silvis S, Jacob HS. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med. 1974;290(25):1403–7.
Kagansky N, Levy S, Koren-Morag N, Berger D, Knobler H. Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival. J Intern Med. 2005;257(5):461–8.
Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, Fux A, et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci. 2006;36(1):67–72.
Marik PE, Bedigian MK. Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study. Arch Surg. 1996;131(10):1043–7.
Taylor BE, Huey WY, Buchman TG, Boyle WA, Coopersmith CM. Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit. J Am Coll Surg. 2004;198(2):198–204.
Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010;14(4):R147. Pubmed Central PMCID: 2945130.
Charron T, Bernard F, Skrobik Y, Simoneau N, Gagnon N, Leblanc M. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. Intensive Care Med. 2003;29(8):1273–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Boyle, S.M., Goldfarb, S. (2017). Phosphate Deficiency and the Phosphate-Depletion Syndrome: Pathophysiology, Diagnosis, and Treatment. In: Gutiérrez, O., Kalantar-Zadeh, K., Mehrotra, R. (eds) Clinical Aspects of Natural and Added Phosphorus in Foods. Nutrition and Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6566-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6566-3_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6564-9
Online ISBN: 978-1-4939-6566-3
eBook Packages: MedicineMedicine (R0)